Annual FCF
-$1.75 B
+$212.00 M+10.79%
31 December 2023
Summary:
BeiGene annual free cash flow is currently -$1.75 billion, with the most recent change of +$212.00 million (+10.79%) on 31 December 2023. During the last 3 years, it has fallen by -$243.25 million (-16.10%). BGNE annual FCF is now -46141.32% below its all-time high of $3.81 million, reached on 31 December 2013.BGNE Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
$54.71 M
+$260.25 M+126.62%
30 September 2024
Summary:
BeiGene quarterly free cash flow is currently $54.71 million, with the most recent change of +$260.25 million (+126.62%) on 30 September 2024. Over the past year, it has increased by +$315.16 million (+121.01%). BGNE quarterly FCF is now -26.87% below its all-time high of $74.82 million, reached on 31 December 2017.BGNE Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$1.04 B
+$315.16 M+23.24%
30 September 2024
Summary:
BeiGene TTM free cash flow is currently -$1.04 billion, with the most recent change of +$315.16 million (+23.24%) on 30 September 2024. Over the past year, it has increased by +$812.38 million (+43.83%). BGNE TTM FCF is now -14893.48% below its all-time high of -$6.94 million, reached on 31 March 2015.BGNE TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BGNE Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +10.8% | +121.0% | +43.8% |
| 3 y3 years | -16.1% | +109.7% | +22.0% |
| 5 y5 years | -154.7% | +118.5% | -17.8% |
BGNE Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -16.1% | +10.8% | at high | +107.9% | at high | +54.7% |
| 5 y | 5 years | -154.7% | +10.8% | -26.3% | +107.9% | -17.8% | +54.7% |
| alltime | all time | <-9999.0% | +10.8% | -26.9% | +107.9% | <-9999.0% | +54.7% |
BeiGene Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $54.71 M(-126.6%) | -$1.04 B(-23.2%) |
| June 2024 | - | -$205.54 M(-59.0%) | -$1.36 B(-13.4%) |
| Mar 2024 | - | -$501.62 M(+29.1%) | -$1.57 B(-10.7%) |
| Dec 2023 | -$1.75 B(-10.8%) | -$388.55 M(+49.2%) | -$1.75 B(-5.4%) |
| Sept 2023 | - | -$260.44 M(-37.3%) | -$1.85 B(-18.8%) |
| June 2023 | - | -$415.36 M(-39.7%) | -$2.28 B(-0.6%) |
| Mar 2023 | - | -$689.36 M(+41.2%) | -$2.30 B(+16.9%) |
| Dec 2022 | -$1.97 B(+21.8%) | -$488.21 M(-29.3%) | -$1.97 B(-8.3%) |
| Sept 2022 | - | -$690.56 M(+60.5%) | -$2.14 B(+6.3%) |
| June 2022 | - | -$430.25 M(+20.6%) | -$2.02 B(-1.4%) |
| Mar 2022 | - | -$356.69 M(-46.5%) | -$2.04 B(+26.7%) |
| Dec 2021 | -$1.61 B(+6.8%) | -$666.23 M(+18.4%) | -$1.61 B(+20.9%) |
| Sept 2021 | - | -$562.76 M(+22.7%) | -$1.33 B(+11.8%) |
| June 2021 | - | -$458.80 M(-718.3%) | -$1.19 B(+15.9%) |
| Mar 2021 | - | $74.21 M(-119.2%) | -$1.03 B(-31.8%) |
| Dec 2020 | -$1.51 B(+66.2%) | -$387.02 M(-8.2%) | -$1.51 B(+5.9%) |
| Sept 2020 | - | -$421.42 M(+42.6%) | -$1.43 B(+9.7%) |
| June 2020 | - | -$295.55 M(-27.3%) | -$1.30 B(+19.0%) |
| Mar 2020 | - | -$406.48 M(+34.3%) | -$1.09 B(+20.2%) |
| Dec 2019 | -$908.88 M | -$302.64 M(+2.3%) | -$908.88 M(+2.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2019 | - | -$295.88 M(+238.0%) | -$883.72 M(+18.3%) |
| June 2019 | - | -$87.55 M(-60.7%) | -$746.96 M(-5.1%) |
| Mar 2019 | - | -$222.80 M(-19.7%) | -$787.16 M(+14.3%) |
| Dec 2018 | -$688.55 M(+1397.6%) | -$277.48 M(+74.4%) | -$688.55 M(+104.8%) |
| Sept 2018 | - | -$159.13 M(+24.6%) | -$336.26 M(+77.6%) |
| June 2018 | - | -$127.75 M(+2.9%) | -$189.32 M(+49.0%) |
| Mar 2018 | - | -$124.20 M(-266.0%) | -$127.08 M(+176.4%) |
| Dec 2017 | -$45.98 M(-59.3%) | $74.82 M(-713.7%) | -$45.98 M(-70.3%) |
| Sept 2017 | - | -$12.19 M(-81.4%) | -$154.99 M(-10.8%) |
| June 2017 | - | -$65.50 M(+52.0%) | -$173.76 M(+30.7%) |
| Mar 2017 | - | -$43.10 M(+26.0%) | -$132.97 M(+17.7%) |
| Dec 2016 | -$113.02 M(+150.3%) | -$34.20 M(+10.5%) | -$113.02 M(+14.2%) |
| Sept 2016 | - | -$30.96 M(+25.3%) | -$99.00 M(+25.7%) |
| June 2016 | - | -$24.71 M(+6.8%) | -$78.78 M(+28.4%) |
| Mar 2016 | - | -$23.14 M(+14.7%) | -$61.36 M(+35.9%) |
| Dec 2015 | -$45.16 M(+383.1%) | -$20.18 M(+87.9%) | -$45.16 M(+80.8%) |
| Sept 2015 | - | -$10.74 M(+47.4%) | -$24.97 M(+75.5%) |
| June 2015 | - | -$7.29 M(+5.0%) | -$14.23 M(+105.0%) |
| Mar 2015 | - | -$6.94 M | -$6.94 M |
| Dec 2014 | -$9.35 M(-345.4%) | - | - |
| Dec 2013 | $3.81 M | - | - |
FAQ
- What is BeiGene annual free cash flow?
- What is the all time high annual FCF for BeiGene?
- What is BeiGene annual FCF year-on-year change?
- What is BeiGene quarterly free cash flow?
- What is the all time high quarterly FCF for BeiGene?
- What is BeiGene quarterly FCF year-on-year change?
- What is BeiGene TTM free cash flow?
- What is the all time high TTM FCF for BeiGene?
- What is BeiGene TTM FCF year-on-year change?
What is BeiGene annual free cash flow?
The current annual FCF of BGNE is -$1.75 B
What is the all time high annual FCF for BeiGene?
BeiGene all-time high annual free cash flow is $3.81 M
What is BeiGene annual FCF year-on-year change?
Over the past year, BGNE annual free cash flow has changed by +$212.00 M (+10.79%)
What is BeiGene quarterly free cash flow?
The current quarterly FCF of BGNE is $54.71 M
What is the all time high quarterly FCF for BeiGene?
BeiGene all-time high quarterly free cash flow is $74.82 M
What is BeiGene quarterly FCF year-on-year change?
Over the past year, BGNE quarterly free cash flow has changed by +$315.16 M (+121.01%)
What is BeiGene TTM free cash flow?
The current TTM FCF of BGNE is -$1.04 B
What is the all time high TTM FCF for BeiGene?
BeiGene all-time high TTM free cash flow is -$6.94 M
What is BeiGene TTM FCF year-on-year change?
Over the past year, BGNE TTM free cash flow has changed by +$812.38 M (+43.83%)